Clinical Trial Update: A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer [Phase 2]

View source ↗

Summary

The document discusses a master protocol (LY900023) with multiple Phase 2 pediatric and young adult cancer trials, currently recruiting. It outlines the sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adolescent Cancer
• Cancer

Drugs mentioned

• LY900023

Snippet

Sponsor: Eli Lilly and Company | Conditions: Neoplasms, Child | Phase 2 | Status: RECRUITING